Fingerprint
Dive into the research topics of 'The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The cyclin kinase inhibitor p21(WAF1/CIP1) is required for glomerular hypertrophy in experimental diabetic nephropathy
Mouhannad Al-Douahji, James Brugarolas, Paul A J Brown, Catherine O. Stehman-Breen, Charles E. Alpers, Stuart J. Shankland
Research output: Contribution to journal › Article › peer-review
118
Scopus
citations